What is Cartalax?
Cartalax is a synthetic tripeptide with the sequence Ala-Glu-Asp (AED). It is one of the short “peptide bioregulators” studied by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology. In that group’s published work it is associated with the joints.
Cartalax product specifications
- Compound: Cartalax
- Sequence: Ala-Glu-Asp (AED, 3 amino acids)
- Molecular formula: C12H19N3O8
- Molecular weight: about 333.3 g/mol
- Vial size: 20mg
Regulatory status
Cartalax is not an approved medicine in the US, UK, EU or Canada. Most published research on it comes from a single research group, so independent confirmation is limited. This product is sold for laboratory research use only.
Related bioregulator peptides
- Epithalon (AEDG) shares the Ala-Glu-Asp start of its sequence.
- Bronchogen (AEDL) and Cardiogen (AEDR) are related tetrapeptides.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
Reviews
There are no reviews yet.